CVMP opinions on veterinary medicinal products

The Committee adopted a positive opinion for a marketing authorisation from Elanco GmbH for Varenzin (molidustat), for the management of non-regenerative anaemia associated with chronic kidney disease (CKD) in cats, by increasing haematocrit/ packed cell volume.

The Committee adopted a positive opinion, in exceptional circumstances, for a marketing authorisation from Laboratorios Syva S.A. for Epizootic haemorrhagic disease vaccine for the active immunisation of cattle to reduce viraemia and fever caused by epizootic haemorrhagic disease virus serotype 8.

The Committee adopted a positive opinion for a marketing authorisation from CP-Pharma Handelsgesellschaft mbH for Firocoxib CP-Pharma (firocoxib), for the relief of pain and inflammation associated with osteoarthritis and for the relief of post-operative pain and inflammation associated with soft-tissue, orthopaedic and dental surgery in dogs.

The Committee adopted a positive…